Skip to main content
Erschienen in: The Patient - Patient-Centered Outcomes Research 1/2018

01.02.2018 | Short Communication

Measuring Health-Related Quality of Life in Adolescent Populations: An Empirical Comparison of the CHU9D and the PedsQLTM 4.0 Short Form 15

verfasst von: Karin Dam Petersen, Gang Chen, Christine Mpundu-Kaambwa, Katherine Stevens, John Brazier, Julie Ratcliffe

Erschienen in: The Patient - Patient-Centered Outcomes Research | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Objective

The aim was to conduct an empirical assessment of the measurement properties of the preference-based Child Health Utility 9D (CHU9D) versus the non-preference-based Pediatric Quality of Life Inventory (PedsQL)™ 4.0 Short Form 15 Generic Core Scales (referred to as ‘PedsQL’) in an Australian community-based sample of adolescents.

Methods

An online survey including the CHU9D, the PedsQL, a self-reported general health question, and socio-demographic questions was administered to adolescents (aged 15–17 years). Descriptive summary statistics and psychometric analyses were conducted to assess levels of agreement and convergent validity between the instruments.

Results

A total of 775 adolescents (mean ± SD age 15.8 ± 0.8 years) completed the survey. The mean ± SD scores of the CHU9D and the PedsQL were 0.72 ± 0.22 and 72.86 ± 16.56, respectively. For both instruments, there were significant differences in health-related quality of life scores according to self-reported health status and socio-economic status. Overall, both the Spearman’s correlation (r = 0.63) and the intraclass correlation coefficient (0.77) suggested a high level of agreement.

Conclusions

The findings indicate good levels of agreement overall between the CHU9D and PedsQL and provide further support for the validity of the application of the CHU9D in the economic evaluation of adolescent health care treatment and service programmes.
Literatur
1.
Zurück zum Zitat Brazier JE, Ratcliffe J, Salomon J, Tsuchiya A. Measuring and valuing health benefits for economic evaluation. 2nd ed. Oxford: Oxford University; 2016.CrossRef Brazier JE, Ratcliffe J, Salomon J, Tsuchiya A. Measuring and valuing health benefits for economic evaluation. 2nd ed. Oxford: Oxford University; 2016.CrossRef
2.
Zurück zum Zitat Prosser LA, Hammitt JK, Keren R. Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children theoretical and methodological considerations. PharmacoEconomics. 2007;25(9):713–26.CrossRefPubMed Prosser LA, Hammitt JK, Keren R. Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children theoretical and methodological considerations. PharmacoEconomics. 2007;25(9):713–26.CrossRefPubMed
3.
Zurück zum Zitat Ratcliffe J, Stevens K, Flynn T, Brazier J, Sawyer MG. Whose values in health? An empirical comparison of the application of adolescent and adult values for the CHU-9D and AQOL-6D in the Australian adolescent general population. Value Health. 2012;15(5):730–6.CrossRefPubMed Ratcliffe J, Stevens K, Flynn T, Brazier J, Sawyer MG. Whose values in health? An empirical comparison of the application of adolescent and adult values for the CHU-9D and AQOL-6D in the Australian adolescent general population. Value Health. 2012;15(5):730–6.CrossRefPubMed
4.
Zurück zum Zitat Ratcliffe J, Chen G, Stevens K, Bradley S, Couzner L, Brazier J, et al. Valuing Child Health Utility 9D health states with young adults: insights from a time trade off study. Appl Health Econ Health Policy. 2015;13(5):485–92.CrossRefPubMed Ratcliffe J, Chen G, Stevens K, Bradley S, Couzner L, Brazier J, et al. Valuing Child Health Utility 9D health states with young adults: insights from a time trade off study. Appl Health Econ Health Policy. 2015;13(5):485–92.CrossRefPubMed
5.
Zurück zum Zitat Williams PG, Holmbeck GN, Greenley RN. Adolescent health psychology. J Consult Clin Psychol. 2002;70(3):828–42.CrossRefPubMed Williams PG, Holmbeck GN, Greenley RN. Adolescent health psychology. J Consult Clin Psychol. 2002;70(3):828–42.CrossRefPubMed
6.
Zurück zum Zitat Frisén A. Measuring health-related quality of life in adolescence. Acta Paediatr. 2007;96(7):963–8.CrossRefPubMed Frisén A. Measuring health-related quality of life in adolescence. Acta Paediatr. 2007;96(7):963–8.CrossRefPubMed
7.
Zurück zum Zitat Chen G, Ratcliffe J. A review of the development and application of generic multi-attribute utility instruments for paediatric populations. PharmacoEconomics. 2015;33(10):1013–28.CrossRefPubMed Chen G, Ratcliffe J. A review of the development and application of generic multi-attribute utility instruments for paediatric populations. PharmacoEconomics. 2015;33(10):1013–28.CrossRefPubMed
8.
Zurück zum Zitat Stevens K. Developing a descriptive system for a new preference-based measure of health-related quality of life for children. Qual Life Res. 2009;18(8):1105–13.CrossRefPubMed Stevens K. Developing a descriptive system for a new preference-based measure of health-related quality of life for children. Qual Life Res. 2009;18(8):1105–13.CrossRefPubMed
9.
Zurück zum Zitat Stevens KJ. Working with children to develop dimensions for a preference-based, generic, pediatric, health-related quality-of-life measure. Qual Health Res. 2010;20(3):340–51.CrossRefPubMed Stevens KJ. Working with children to develop dimensions for a preference-based, generic, pediatric, health-related quality-of-life measure. Qual Health Res. 2010;20(3):340–51.CrossRefPubMed
10.
Zurück zum Zitat Varni JW, Burwinkle TM, Seid M. The PedsQLTM as a pediatric patient-reported outcome: reliability and validity of the PedsQLTM measurement model in 25,000 children. Expert Rev Pharmacoecon Outcomes Res. 2005;5(6):705–19.CrossRefPubMed Varni JW, Burwinkle TM, Seid M. The PedsQLTM as a pediatric patient-reported outcome: reliability and validity of the PedsQLTM measurement model in 25,000 children. Expert Rev Pharmacoecon Outcomes Res. 2005;5(6):705–19.CrossRefPubMed
11.
Zurück zum Zitat Mpundu-Kaambwa C, Chen G, Russo R, Stevens K, Petersen KD, Ratcliffe J. Mapping CHU9D utility scores from the PedsQLTM 4.0 SF-15. PharmacoEconomics. 2017;35(4):453–67.CrossRefPubMed Mpundu-Kaambwa C, Chen G, Russo R, Stevens K, Petersen KD, Ratcliffe J. Mapping CHU9D utility scores from the PedsQLTM 4.0 SF-15. PharmacoEconomics. 2017;35(4):453–67.CrossRefPubMed
12.
Zurück zum Zitat Boyce W, Torsheim T, Currie C, Zambon A. The family affluence scale as a measure of national wealth: validation of an adolescent self-report measure. Soc Indic Res. 2006;78(3):473–87.CrossRef Boyce W, Torsheim T, Currie C, Zambon A. The family affluence scale as a measure of national wealth: validation of an adolescent self-report measure. Soc Indic Res. 2006;78(3):473–87.CrossRef
13.
Zurück zum Zitat Ratcliffe J, Stevens K, Flynn T, Brazier J, Sawyer M. An assessment of the construct validity of the CHU9D in the Australian adolescent general population. Qual Life Res. 2012;21(4):717–25.CrossRefPubMed Ratcliffe J, Stevens K, Flynn T, Brazier J, Sawyer M. An assessment of the construct validity of the CHU9D in the Australian adolescent general population. Qual Life Res. 2012;21(4):717–25.CrossRefPubMed
14.
Zurück zum Zitat Chen G, Flynn T, Stevens K, Brazier J, Huynh E, Sawyer M, et al. Assessing the health-related quality of life of Australian adolescents: an empirical comparison of the Child Health Utility 9D and EQ-5D-Y instruments. Value Health. 2015;18(4):432–8.CrossRefPubMed Chen G, Flynn T, Stevens K, Brazier J, Huynh E, Sawyer M, et al. Assessing the health-related quality of life of Australian adolescents: an empirical comparison of the Child Health Utility 9D and EQ-5D-Y instruments. Value Health. 2015;18(4):432–8.CrossRefPubMed
15.
Zurück zum Zitat Chan KS, Mangione-Smith R, Burwinkle TM, Rosen M, Varni JW. The PedsQLTM: reliability and validity of the short-form generic core scales and Asthma Module. Med Care. 2005;43(3):256–65.CrossRefPubMed Chan KS, Mangione-Smith R, Burwinkle TM, Rosen M, Varni JW. The PedsQLTM: reliability and validity of the short-form generic core scales and Asthma Module. Med Care. 2005;43(3):256–65.CrossRefPubMed
16.
Zurück zum Zitat Stevens K. Valuation of the Child Health Utility Index 9D (CHU9D). Pharmacoeconomics. 2010;30(8):729–47.CrossRef Stevens K. Valuation of the Child Health Utility Index 9D (CHU9D). Pharmacoeconomics. 2010;30(8):729–47.CrossRef
17.
Zurück zum Zitat Stevens K. Assessing the performance of a new generic measure of health related quality of life for children and refining it for use in health state valuation. Appl Health Econ Health Policy. 2011;9(3):157–69.CrossRefPubMed Stevens K. Assessing the performance of a new generic measure of health related quality of life for children and refining it for use in health state valuation. Appl Health Econ Health Policy. 2011;9(3):157–69.CrossRefPubMed
18.
Zurück zum Zitat Stevens K, Ratcliffe J. Measuring and valuing health benefits for economic evaluation in adolescence: an assessment of the practicality and validity of the Child Health Utility 9D in the Australian adolescent population. Value Health. 2012;15(8):1092–9.CrossRefPubMed Stevens K, Ratcliffe J. Measuring and valuing health benefits for economic evaluation in adolescence: an assessment of the practicality and validity of the Child Health Utility 9D in the Australian adolescent population. Value Health. 2012;15(8):1092–9.CrossRefPubMed
19.
Zurück zum Zitat Ratcliffe J, Huynh E, Chen G, Stevens K, Swait J, Brazier J, et al. Valuing the Child Health Utility 9D: using profile case best worst scaling methods to develop a new adolescent specific scoring algorithm. Soc Sci Med. 2016;157:48–59.CrossRefPubMed Ratcliffe J, Huynh E, Chen G, Stevens K, Swait J, Brazier J, et al. Valuing the Child Health Utility 9D: using profile case best worst scaling methods to develop a new adolescent specific scoring algorithm. Soc Sci Med. 2016;157:48–59.CrossRefPubMed
20.
Zurück zum Zitat Walters SJ. Quality of life outcomes in clinical trials and health-care evaluation: a practical guide to analysis and interpretation. Chichester: Wiley; 2009.CrossRef Walters SJ. Quality of life outcomes in clinical trials and health-care evaluation: a practical guide to analysis and interpretation. Chichester: Wiley; 2009.CrossRef
21.
Zurück zum Zitat von Rueden U, Gosch A, Rajmil L, Bisegger C, Ravens-Sieberer U. Socioeconomic determinants of health related quality of life in childhood and adolescence: results from a European study. J Epidemiol Community Health. 2006;60(2):130–5.CrossRef von Rueden U, Gosch A, Rajmil L, Bisegger C, Ravens-Sieberer U. Socioeconomic determinants of health related quality of life in childhood and adolescence: results from a European study. J Epidemiol Community Health. 2006;60(2):130–5.CrossRef
22.
Zurück zum Zitat Fleiss JL, Cohen J. The equivalence of weighted Kappa and the intraclass correlation coefficient as measures of reliability. Educ Psychol Meas. 1973;33:613–9.CrossRef Fleiss JL, Cohen J. The equivalence of weighted Kappa and the intraclass correlation coefficient as measures of reliability. Educ Psychol Meas. 1973;33:613–9.CrossRef
23.
Zurück zum Zitat Anderson TW, Finn J. The new statistical analysis of data. New York: Springer; 1996.CrossRef Anderson TW, Finn J. The new statistical analysis of data. New York: Springer; 1996.CrossRef
24.
Zurück zum Zitat Drummond M. Introducing economic and quality of life measurements into clinical studies. Ann Med. 2001;33:344–9.CrossRefPubMed Drummond M. Introducing economic and quality of life measurements into clinical studies. Ann Med. 2001;33:344–9.CrossRefPubMed
25.
Zurück zum Zitat Varni JW, Burwinkle TM, Seid M. The PedsQL™ as a pediatric patient-reported outcome: reliability and validity of the PedsQL™ Measurement Model in 25,000 children. Expert Rev Pharmacoeconomics Outcomes Res. 2005;5(6):705–19.CrossRef Varni JW, Burwinkle TM, Seid M. The PedsQL™ as a pediatric patient-reported outcome: reliability and validity of the PedsQL™ Measurement Model in 25,000 children. Expert Rev Pharmacoeconomics Outcomes Res. 2005;5(6):705–19.CrossRef
26.
Zurück zum Zitat Parkinson B, Sermet C, Clement F, Crausaz S, Godman B, Garner S, et al. Disinvestment and value-based purchasing strategies for pharmaceuticals: an international review. Pharmacoeconomics. 2015;33(9):905–24.CrossRefPubMed Parkinson B, Sermet C, Clement F, Crausaz S, Godman B, Garner S, et al. Disinvestment and value-based purchasing strategies for pharmaceuticals: an international review. Pharmacoeconomics. 2015;33(9):905–24.CrossRefPubMed
27.
28.
Zurück zum Zitat Marshall HS, Chen G, Clarke M, Ratcliffe J. Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: a discrete choice experiment. Vaccine. 2016;34(5):671–7.CrossRefPubMed Marshall HS, Chen G, Clarke M, Ratcliffe J. Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: a discrete choice experiment. Vaccine. 2016;34(5):671–7.CrossRefPubMed
Metadaten
Titel
Measuring Health-Related Quality of Life in Adolescent Populations: An Empirical Comparison of the CHU9D and the PedsQLTM 4.0 Short Form 15
verfasst von
Karin Dam Petersen
Gang Chen
Christine Mpundu-Kaambwa
Katherine Stevens
John Brazier
Julie Ratcliffe
Publikationsdatum
01.02.2018
Verlag
Springer International Publishing
Erschienen in
The Patient - Patient-Centered Outcomes Research / Ausgabe 1/2018
Print ISSN: 1178-1653
Elektronische ISSN: 1178-1661
DOI
https://doi.org/10.1007/s40271-017-0265-5

Weitere Artikel der Ausgabe 1/2018

The Patient - Patient-Centered Outcomes Research 1/2018 Zur Ausgabe